Evidence map›Paper›PMID 24972488›Full record

ArticleCell calcium2014

Characterization of ryanodine receptor type 1 single channel activity using "on-nucleus" patch clamp.

Larry E Wagner, Linda A Groom, Robert T Dirksen, David I Yule

Open access · greenAbstract read
In one paragraph

Article in Cell calcium, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. NAADP: From Discovery to Mechanism.Frontiers in immunology · 2021
    Review
  3. NAADP Receptors.Cold Spring Harbor perspectives in biology · 2019
    Review
  4. Review
  5. Single-channel recordings of RyR1 at microsecond resolution in CMOS-suspended membranes.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  6. Article
  7. Mind the magnesium, in dantrolene suppression of malignant hyperthermia.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  8. Dantrolene requires MgProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. Article
  10. Review
  11. Preferential Coupling of the NAADP Pathway to Exocytosis in T-Cells.Messenger (Los Angeles, Calif. : Print) · 2015
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Larry E WagnerDepartment of Pharmacology and Physiology, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642, United States.
Linda A GroomDepartment of Pharmacology and Physiology, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642, United States.
Robert T DirksenDepartment of Pharmacology and Physiology, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642, United States.
David I YuleDepartment of Pharmacology and Physiology, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642, United States. Electronic address: David_Yule@urmc.rochester.edu.
University of Rochester · USUniversity of Rochester Medical Center · US

Funding

[Ca2+]i and Secretory Dynamics in Parotid Acinar CellsR01DE014756 · NIDCR · UNIVERSITY OF ROCHESTER · PI David I Yule · 2002 to 2026
$9.9M
An experimental/computational approach for understanding salivary fluid secretionR01DE019245 · NIDCR · UNIVERSITY OF ROCHESTER · PI David I Yule · 2008 to 2026
$9.7M
Basis of Muscle Dysfunction in Malignant Hyperthermia & Central Core DiseaseR01AR053349 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI DIRKSEN, ROBERT T, HAMILTON, SUSAN L · 2006 to 2020
$8.0M
[Ca2+]i and Secretory Dynamics in Parotid Acinar CellsR56DE014756 · NIDCR · UNIVERSITY OF ROCHESTER · PI YULE, DAVID I · 2007 to 2007
$395k
NIAMS NIH HHS AR053349NIAMS NIH HHS R01 AR053349NIDCR NIH HHS DE014756NIDCR NIH HHS DE019245NIDCR NIH HHS R01 DE014756NIDCR NIH HHS R01 DE019245NIDCR NIH HHS R56 DE014756
6 · The paper itself

Abstract

In this study, we provide the first description of the biophysical and pharmacological properties of ryanodine receptor type 1 (RyR1) expressed in a native membrane using the on-nucleus configuration of the patch clamp technique. A stable cell line expressing rabbit RyR1 was established (HEK-RyR1) using the FLP-in 293 cell system. In contrast to untransfected cells, RyR1 expression was readily demonstrated by immunoblotting and immunocytochemistry in HEK-RyR1 cells. In addition, the RyR1 agonists 4-CMC and caffeine activated Ca(2+) release that was inhibited by high concentrations of ryanodine. On nucleus patch clamp was performed in nuclei prepared from HEK-RyR1 cells. Raising the [Ca(2+)] in the patch pipette resulted in the appearance of a large conductance cation channel with well resolved kinetics and the absence of prominent subconductance states. Current versus voltage relationships were ohmic and revealed a chord conductance of ∼750pS or 450pS in symmetrical 250mM KCl or CsCl, respectively. The channel activity was markedly enhanced by caffeine and exposure to ryanodine resulted in the appearance of a subconductance state with a conductance ∼40% of the full channel opening with a Po near unity. In total, these properties are entirely consistent with RyR1 channel activity. Exposure of RyR1 channels to cyclic ADP ribose (cADPr), nicotinic acid adenine dinucleotide phosphate (NAADP) or dantrolene did not alter the single channel activity stimulated by Ca(2+), and thus, it is unlikely these molecules directly modulate RyR1 channel activity. In summary, we describe an experimental platform to monitor the single channel properties of RyR channels. We envision that this system will be influential in characterizing disease-associated RyR mutations and the molecular determinants of RyR channel modulation.

Indexed as

AnimalsCaffeineCalciumCalcium Channel AgonistsCell NucleusCesiumChloridesEndoplasmic ReticulumHEK293 CellsHumansPatch-Clamp TechniquesPotassium ChlorideRabbitsRyanodineRyanodine Receptor Calcium Release ChannelSignal TransductionCaffeineCalciumCalcium Channel AgonistsCesiumcesium chlorideChloridesPotassium ChlorideRyanodineRyanodine Receptor Calcium Release ChannelInositol 1,4,5-trisphosphate receptorRyanodine receptorSingle channel measurement

Identifiers

PMID24972488
PMCPMC4120733
OpenAlexW2044661137

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.